RAPTOR PHARMACEUTICAL CORP's ticker is RPTP and the CUSIP is 75382F106. A total of 103 filers reported holding RAPTOR PHARMACEUTICAL CORP in Q2 2015. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $158,000 | -24.8% | 10,000 | -50.0% | 0.01% | -14.3% |
| Q4 2014 | $210,000 | +9.4% | 20,000 | 0.0% | 0.01% | +40.0% |
| Q3 2014 | $192,000 | -11.9% | 20,000 | +5.8% | 0.01% | 0.0% |
| Q2 2014 | $218,000 | -41.1% | 18,900 | -48.9% | 0.01% | -28.6% |
| Q1 2014 | $370,000 | +105.6% | 37,000 | +168.3% | 0.01% | +75.0% |
| Q4 2013 | $180,000 | – | 13,790 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 888,132 | $4,618,000 | 3.71% |
| GREAT POINT PARTNERS LLC | 1,282,527 | $6,669,000 | 2.80% |
| Broadfin Capital, LLC | 2,412,995 | $12,548,000 | 0.77% |
| SPHERA FUNDS MANAGEMENT LTD. | 685,000 | $3,562,000 | 0.52% |
| GLOBEFLEX CAPITAL L P | 209,787 | $1,091,000 | 0.29% |
| TFS CAPITAL LLC | 477,884 | $2,485,000 | 0.27% |
| FT Options LLC | 127,400 | $220,000 | 0.16% |
| Tourbillon Capital Partners, L.P. | 1,264,999 | $6,578,000 | 0.15% |
| Birchview Capital, LP | 40,000 | $208,000 | 0.12% |
| SECOR Capital Advisors, LP | 70,111 | $365,000 | 0.10% |